Where does Immunexpress PTY Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immunexpress PTY Ltd ranks #26,530 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immunexpress PTY Ltd hold?

Immunexpress PTY Ltd holds 10 US utility patents granted between 2017 and 2024, spanning 6 technology areas.

What is Immunexpress PTY Ltd's Innovation Score?

Immunexpress PTY Ltd has an Innovation Score of 23.2 out of 100 (12th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Immunexpress PTY Ltd's patent grant rate increasing or decreasing?

Immunexpress PTY Ltd's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Immunexpress PTY Ltd's patents?

Immunexpress PTY Ltd's patents average 7.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immunexpress PTY Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immunexpress PTY Ltd

Q: What technology areas does Immunexpress PTY Ltd focus on?

Immunexpress PTY Ltd's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 10 patents, ranking #452 of 2,502 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immunexpress ranks #26,530 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#26,530
of 49,997 US assignees by volume: 12th percentile
by Innovation Score (23.2/100): 7.2
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26530 · Foreign Corporation #26,530 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,530/49,997
PHOTO-FINISH Ilsco
CPC-NARROW C12Q · 6 areas
INNOV-THIN 23.2/100
CLAIMS-SPARSE 7.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ilsco, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Immunexpress’s 23.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (36%) Velocity 1.9 pts (8%) Breadth 8.7 pts (38%) Claim depth 4.3 pts (19%)

Qualcomm Incorporated · highest

85
Immunexpress PTY · this assignee

23
3D Lighting… · lowest

7

What this shows Immunexpress's Innovation Score is 23.2/100 (12th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Immunexpress?

Each dot is one of Immunexpress’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Immunexpress’s own 7.2 claims/patent is at or below the 17.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Immunexpress vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Immunexpress's grants concentrate

Immunexpress PTY Ltd is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Immunexpress sits between Ilsco, LLC and Inbiomotion S.L..

Immunexpress's three-year grant acceleration

Immunexpress PTY Ltd shows 2 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ilsco

10
IMA Life North Am…

10
Imec Taiwan

10
IML Instrumenta M…

10
Impact Products

10
Imricor Medical S…

10
IMS Gear

10
Inbiomotion S L

10
Immunexpress PTY ◀

10

What this shows Immunexpress holds 10 patents at rank #26,517, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immunexpress

By rank, the assignees closest to #26,517 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Immunexpress's primary technology class.

Immunexpress's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 12th percentile higher than 12% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Immunexpress PTY Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	10.0%
2019	3	30.0%
2020	2	20.0%
2021	2	20.0%
2024	2	20.0%

Which technologies does Immunexpress PTY Ltd patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 8

Y02A - Technologies FOR Adaptation TO Climate Change 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Immunexpress PTY Ltd's patent record in context - here's where to go next.

Immunexpress PTY Ltd's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #26,530 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immunexpress PTY Ltd against Ilsco, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.